Official Project Description
This project simulates small macrocyclic inhibitors of HDAC8 (histone deacetylase 8), a therapeutic target for certain types of cancer.
This work, a collaboration with Kathryn Cole's group at Christopher Newport University, aims to understand the conformational flexibility of these ligands in solution and bound to the HDAC8 receptor.